PCRX
Pacira BioScienc (PCRX)
NASDAQ
$26.53+$0.12 (+0.47%)
Price as of Aug 03, 2026 11:33 AM EDT
  • $1.0B
    Market Cap
  • 19.66%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 33
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 12
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
-1.50%
12-Month Momentum
18.68%
3-Month Risk Adjusted Momentum
-11.30%
12-Month Risk Adjusted Momentum
52.15%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
10.94%
Net Debt Paydown Yield
-7.67%

Financial Health Score

Score: 74
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7